KIP Infracstructure
0.2.1 - release
This page is part of the KIP Infrastructure (v0.2.1: Release) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 2.9.0. For a full list of available versions, see the Directory of published versions
| Official URL: https://kip.rkkp.dk/fhir/ValueSet/BehandlingCML | Version: 0.2.1 | |||
| Active as of 2022-07-18 | Computable Name: BehandlingCML | |||
Behandling (CML)
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet BehandlingCML
This value set includes codes based on the following rules:
https://kip.rkkp.dk/fhir/CodeSystem/ATC| Code | Display | Definition |
| L01EA06 | Asciminib | L01EA06 - Asciminib |
| L01XX05 | Hydroxycarbamide | L01XX05 - hydroxycarbamide |
| L01EA01 | Imatinib | L01EA01 - imatinib |
| L01EA02 | Dasatinib | L01EA02 - dasatinib |
| L01EA03 | Nilotinib | L01EA03 - nilotinib |
| L03AB | Interferon | L03AB - Interferons |
| L01EA04 | Bosutinib | L01EA04 - bosutinib |
| L01EA05 | Ponatinib | L01EA05 - ponatinib |
https://kip.rkkp.dk/fhir/CodeSystem/ATCMixedCodes
| Code | Display | Definition |
| tki | Anden TKI behandling | TKI (Tyrosine kinase inhibitors) |
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues
| Code | Display | Definition |
| other | Anden behandling | Other - used to choose unspecific value not in a valueset |
ValueSet
Expansion performed internally based on:
This value set contains 10 concepts
| Code | System | Display (en-US) | Definition |
| L01EA06 | https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01EA06 - Asciminib | |
| L01XX05 | https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01XX05 - hydroxycarbamide | |
| L01EA01 | https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01EA01 - imatinib | |
| L01EA02 | https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01EA02 - dasatinib | |
| L01EA03 | https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01EA03 - nilotinib | |
| L03AB | https://kip.rkkp.dk/fhir/CodeSystem/ATC | L03AB - Interferons | |
| L01EA04 | https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01EA04 - bosutinib | |
| L01EA05 | https://kip.rkkp.dk/fhir/CodeSystem/ATC | L01EA05 - ponatinib | |
| tki | https://kip.rkkp.dk/fhir/CodeSystem/ATCMixedCodes | TKI (Tyrosine kinase inhibitors) | |
| other | https://kip.rkkp.dk/fhir/CodeSystem/GenericValues | Other - used to choose unspecific value not in a valueset |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |